Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05348447 · ClinicalTrials.gov registry record · NA

Intercostal Nerve Cryotherapy in Patients Undergoing Minimally Invasive Pulmonary Resection

A NA study of Pain, Postoperative and Cryotherapy Effect, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

Active
Registry status
NA
Development phase
110
Enrollment target
1
Study location

NCT05348447: Active NA study of Pain, Postoperative and Cryotherapy Effect, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

NCT05348447 is a NA study of Pain, Postoperative and Cryotherapy Effect that is active but no longer recruiting, run by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). The registered enrollment target is 110 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05348447, a NA study of Pain, Postoperative and Cryotherapy Effect, is active but no longer recruiting, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
110 participants
Enrollment target
1
Study location

Study Summary

This is a research study designed to test whether a treatment called Intercostal Nerve Cryotherapy is an effective way to help control post-surgical pain for patients undergoing minimally invasive pulmonary resection. There are two treatment groups in this study, a cryotherapy group and control group. Cryotherapy is a method of controlling pain by freezing nerves between the ribs that would transmit pain impulses to the brain.

Primary Outcome

total milligrams (mg) of morphine received during hospitalization

Interventions

  • DEVICE cryoanalgesia
  • OTHER Standard of Care Pain Control

Study Locations (1)

Pennsylvania

  • AHN Allegheny General Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2022-04-21
Est. Completion 2026-03-20
Phase NA

What the registry record for NCT05348447 still lists

NCT05348447 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (60% lower).

The record links to 2 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which cryoanalgesia is the first listed.

NCT05348447 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05348447 about?

NCT05348447 is a clinical study titled "Intercostal Nerve Cryotherapy in Patients Undergoing Minimally Invasive Pulmonary Resection". This is a research study designed to test whether a treatment called Intercostal Nerve Cryotherapy is an effective way to help control post-surgical pain for patients undergoing minimally invasive pulmonary resection. There are two treatment groups in this study, a cryotherapy group and control gro...

What is the current status of trial NCT05348447?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2022-04-21. Estimated completion is 2026-03-20.

What conditions does trial NCT05348447 study?

This clinical trial studies the following conditions: Pain, Postoperative, Cryotherapy Effect.

What interventions are being tested in trial NCT05348447?

The interventions under investigation include: cryoanalgesia (DEVICE), Standard of Care Pain Control (OTHER).

Who is sponsoring clinical trial NCT05348447?

This trial is sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05348447 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05348447's enrollment target sits among peer trials

110 41st of 113 higher than 73 of 113 other Pain, Postoperative trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01530373 · 110 participants · Phase 2

    Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

  • NCT02379377 · 110 participants · Phase 1

    18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

  • NCT02411773 · 110 participants · Phase 1

    Sympatholysis in Chronic Kidney Disease

  • NCT03190941 · 110 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05348447, the US trial registry maintained by the National Library of Medicine. NCT05348447 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.